| RS932952740 |
CPLANE1
|
Health Risk |
Pathogenic |
— |
| RS932956802 |
TUFT1
|
Health Risk |
Pathogenic |
Woolly hair-skin fragility syndrome, Woolly hair-skin fragility syndrome |
| RS933026071 |
SLC5A1
|
Health Risk |
Likely pathogenic |
SLC5A1-related disorder, Congenital glucose-galactose malabsorption |
| RS933030670 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS933036653 |
SLC16A2
|
Health Risk |
Pathogenic |
Spastic paraplegia, Allan-Herndon-Dudley syndrome |
| RS933106143 |
ASPM
|
Health Risk |
Pathogenic/Likely pathogenic |
Microcephaly 5, primary |
| RS933114782 |
TGFBR2
|
Health Risk |
Uncertain significance/Uncertain risk allele |
Familial thoracic aortic aneurysm and aortic dissection, Loeys-Dietz syndrome 2 |
| RS933142627 |
RAF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Noonan syndrome 5 |
| RS933169926 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa |
| RS933176029 |
CEP63
|
Health Risk |
Pathogenic |
— |
| RS933195273 |
CYP27A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cholestanol storage disease, Cholestanol storage disease |
| RS9332220 |
CYP2C9
|
Health Risk |
association |
Pulmonary disease, chronic obstructive |
| RS933233143 |
SELENOI
|
Health Risk |
Pathogenic |
Spastic paraplegia 81, autosomal recessive |
| RS933237458 |
FARS2
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation defect type 14, Combined oxidative phosphorylation defect type 14 |
| RS933245871 |
PTPRQ
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 84A, Autosomal recessive nonsyndromic hearing loss 84A |
| RS933257311 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS933258893 |
SCN4A
|
Health Risk |
Pathogenic |
Hyperkalemic periodic paralysis, Congenital myopathy 22B |
| RS9332605 |
F5
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital factor V deficiency, Congenital factor V deficiency |
| RS9332677 |
F5
|
Health Risk |
Conflicting classifications of pathogenicity |
Factor V deficiency, Budd-Chiari syndrome |
| RS9332719 |
C2
|
Health Risk |
Conflicting classifications of pathogenicity |
Age related macular degeneration 14, Complement component 2 deficiency |
| RS933273265 |
AP4B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 47, Hereditary spastic paraplegia |
| RS9332736 |
C2
|
Health Risk |
Pathogenic/Likely pathogenic |
Complement component 2 deficiency, C2 deficiency |
| RS933284199 |
FANCI
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Inborn genetic diseases |
| RS9332960 |
SRD5A2
|
Health Risk |
Pathogenic |
3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency, SRD5A2-related disorder |
| RS9332961 |
SRD5A2
|
Health Risk |
Pathogenic/Likely pathogenic |
3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency, 3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency |
| RS9332964 |
SRD5A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Micropenis, 3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency |
| RS9332966 |
SRD5A2
|
Health Risk |
Conflicting classifications of pathogenicity |
3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency, 3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency |
| RS933296601 |
MTFMT
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined oxidative phosphorylation defect type 15, Inborn genetic diseases |
| RS9332967 |
SRD5A2
|
Health Risk |
Pathogenic/Likely pathogenic |
3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency, SRD5A2-related disorder |
| RS9332969 |
AR
|
Health Risk |
Pathogenic |
Partial androgen insensitivity syndrome, Androgen resistance syndrome |
| RS9332970 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS9332971 |
AR
|
Health Risk |
Pathogenic |
Partial androgen insensitivity syndrome, Androgen resistance syndrome |
| RS9332974 |
WT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilms tumor 1, Nephrotic syndrome |
| RS933331654 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive Alport syndrome, Hematuria |
| RS933333847 |
F11
|
Health Risk |
Pathogenic |
— |
| RS9333378 |
MGST3
|
Health Risk |
association |
Pulmonary disease, chronic obstructive |
| RS9333548 |
POLH
|
Health Risk |
Conflicting classifications of pathogenicity |
Xeroderma pigmentosum variant type, Xeroderma pigmentosum |
| RS933356579 |
BLM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Bloom syndrome |
| RS9333649 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome 2, Congenital long QT syndrome |
| RS933370216 |
CLRN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 3, Usher syndrome type 3 |
| RS933379958 |
FRRS1L
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 37 |
| RS933381749 |
ADAMTS2
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, dermatosparaxis type |
| RS933385444 |
GABBR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS933392379 |
KCNJ11
|
Health Risk |
Conflicting classifications of pathogenicity |
Permanent neonatal diabetes mellitus, Maturity-onset diabetes of the young |
| RS933412369 |
KLF11
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS933422777 |
AGPAT2
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital generalized lipodystrophy type 1, Congenital generalized lipodystrophy type 1 |
| RS933434691 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome |
| RS933464584 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS933476040 |
TTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyloidosis, hereditary systemic 1 |
| RS933498193 |
FYCO1
|
Health Risk |
Pathogenic |
FYCO1-related disorder, FYCO1-related disorder |
| RS933499397 |
ASPM
|
Health Risk |
Likely pathogenic |
Microcephaly 5, primary |
| RS933508115 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS933536639 |
AKAP9
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS933572056 |
TBCD
|
Health Risk |
Pathogenic |
— |
| RS933577333 |
MKS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS933589600 |
COL5A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS933592081 |
ECHS1
|
Health Risk |
Likely pathogenic |
Mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency, Mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency |
| RS933601432 |
CDK13
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS933604666 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS933617964 |
ARID1A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS933624223 |
GCDH
|
Health Risk |
Pathogenic/Likely pathogenic |
Glutaric aciduria, type 1 |
| RS933648254 |
AHI1
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome, Joubert syndrome 3 |
| RS933657325 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group A |
| RS933672395 |
CREBBP
|
Health Risk |
Pathogenic/Likely pathogenic |
Menke-Hennekam syndrome 1, Inborn genetic diseases |
| RS933702160 |
UNC13D
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 3, Familial hemophagocytic lymphohistiocytosis 3 |
| RS933715329 |
PIP5K1A
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder 60 with seizures, Intellectual developmental disorder 60 with seizures |
| RS933746831 |
VPS13B
|
Health Risk |
Pathogenic/Likely pathogenic |
Cohen syndrome, Abnormality of the nervous system |
| RS933777198 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypobetalipoproteinemia 1, Hypercholesterolemia |
| RS933813349 |
CPS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital hyperammonemia, type I |
| RS933815442 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS933828560 |
BCKDHB
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS933842186 |
SNRNP200
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS933885701 |
KCNQ5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS933913059 |
FANCL
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group L, Fanconi anemia |
| RS933980617 |
ERCC6
|
Health Risk |
Pathogenic |
— |
| RS934014841 |
ELN
|
Health Risk |
Conflicting classifications of pathogenicity |
Supravalvar aortic stenosis, Cutis laxa |
| RS934030293 |
ABCB11
|
Health Risk |
Likely pathogenic |
— |
| RS934035216 |
UBE3B
|
Health Risk |
Pathogenic |
— |
| RS934035500 |
SETD2
|
Health Risk |
Likely pathogenic |
SETD2-related disorder, SETD2-related disorder |
| RS934111355 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy |
| RS934115207 |
IDUA
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS934115584 |
ABCG8
|
Health Risk |
Pathogenic |
ABCG8-related disorder, Sitosterolemia 1 |
| RS9341246 |
CYP1B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital glaucoma, Congenital glaucoma |
| RS934138970 |
MTO1
|
Health Risk |
Pathogenic |
Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency, Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency |
| RS934153273 |
KL
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumoral calcinosis, hyperphosphatemic |
| RS934172185 |
PDE6B
|
Health Risk |
Likely pathogenic |
— |
| RS934177451 |
SYNGAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 5 |
| RS934194113 |
OTOG
|
Health Risk |
Likely pathogenic |
— |
| RS934214433 |
GPR179
|
Health Risk |
Pathogenic |
— |
| RS934215303 |
ALPK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS934259733 |
LMBRD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Methylmalonic aciduria and homocystinuria type cblF, Methylmalonic aciduria and homocystinuria type cblF |
| RS934260435 |
TAMM41
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation deficiency 56, Acute myeloid leukemia |
| RS934266733 |
ATP6V0A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive distal renal tubular acidosis, Autosomal recessive distal renal tubular acidosis |
| RS934278063 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
MYH7-related disorder, Hypertrophic cardiomyopathy |
| RS934287314 |
OPTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Amyotrophic lateral sclerosis type 12, Glaucoma 1 |
| RS934317603 |
CREBBP
|
Health Risk |
Conflicting classifications of pathogenicity |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome |
| RS934324267 |
PCNT
|
Health Risk |
Pathogenic |
Microcephalic osteodysplastic primordial dwarfism type II, Microcephalic osteodysplastic primordial dwarfism type II |
| RS934368057 |
DLL3
|
Health Risk |
Conflicting classifications of pathogenicity |
Spondylocostal dysostosis 1, autosomal recessive |
| RS934388592 |
QRICH2
|
Health Risk |
Pathogenic |
Spermatogenic failure 35, Spermatogenic failure 35 |
| RS934411514 |
HADHA
|
Health Risk |
Likely pathogenic |
Mitochondrial trifunctional protein deficiency, Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency |